Evidence map›Paper›PMID 31592077›Full record

ArticleAdvanced pharmaceutical bulletin2019

Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein.

Mahdi Barazesh, Zohreh Mostafavipour, Soudabeh Kavousipour, Shiva Mohammadi, Pooneh Mokarram

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced pharmaceutical bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mahdi BarazeshDepartment of Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran.ORCID https://orcid.org/0000-0003-1303-1116
Zohreh MostafavipourDepartment of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran.ORCID https://orcid.org/0000-0002-3779-177X
Soudabeh KavousipourDepartment of Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Shiva MohammadiDepartment of Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran.ORCID https://orcid.org/0000-0002-7071-3992
Pooneh MokarramDepartment of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran.ORCID https://orcid.org/0000-0002-9717-0473
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoinduction method (AIM)GnRH-DFF40 chimeric proteinHigh cell density IPTG induction (HCDI)Humanized recombinant immunotoxinTargeted therapy

Identifiers

PMID31592077
PMCPMC6773931
OpenAlexW2965859239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.